Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease

Therapeutics discovery and development for Alzheimer’s disease (AD) has been an area of intense research to alleviate memory loss and the underlying pathogenic processes. Recent drug discovery approaches have utilized in silico computational strategies for drug candidate selection which has opened t...

Descripción completa

Detalles Bibliográficos
Autores principales: Boyarko, Ben, Podvin, Sonia, Greenberg, Barry, Momper, Jeremiah D., Huang, Yadong, Gerwick, William H., Bang, Anne G., Quinti, Luisa, Griciuc, Ana, Kim, Doo Yeon, Tanzi, Rudolph E., Feldman, Howard H., Hook, Vivian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436590/
https://www.ncbi.nlm.nih.gov/pubmed/37601062
http://dx.doi.org/10.3389/fphar.2023.1190402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436590/
https://www.ncbi.nlm.nih.gov/pubmed/37601062
http://dx.doi.org/10.3389/fphar.2023.1190402

Ejemplares similares